No abstract available
MeSH terms
-
Administration, Oral
-
Alprostadil / therapeutic use
-
Animals
-
Aspirin / therapeutic use
-
Bridged Bicyclo Compounds / therapeutic use
-
Collagen / toxicity
-
Diltiazem / therapeutic use
-
Drug Evaluation, Preclinical
-
Epinephrine / toxicity
-
Epoprostenol / administration & dosage
-
Epoprostenol / analogs & derivatives*
-
Epoprostenol / therapeutic use
-
Fatty Acids, Monounsaturated / therapeutic use
-
Fibrinolytic Agents / administration & dosage
-
Fibrinolytic Agents / therapeutic use*
-
Heparin / therapeutic use
-
Hydralazine / therapeutic use
-
Injections, Intravenous
-
Isosorbide Dinitrate / therapeutic use
-
Male
-
Mice
-
Nifedipine / therapeutic use
-
Nitroprusside / therapeutic use
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Pulmonary Embolism / chemically induced
-
Pulmonary Embolism / prevention & control*
-
Superoxide Dismutase / therapeutic use
-
Vasodilator Agents / therapeutic use
Substances
-
Bridged Bicyclo Compounds
-
Fatty Acids, Monounsaturated
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors
-
Vasodilator Agents
-
S 145
-
Nitroprusside
-
Hydralazine
-
beraprost
-
Heparin
-
Collagen
-
Epoprostenol
-
Superoxide Dismutase
-
Diltiazem
-
Alprostadil
-
Nifedipine
-
Isosorbide Dinitrate
-
Aspirin
-
Epinephrine